Grafton demineralized bone matrix gel
specific form of DBM that includes a functional carrier, Glycerol USP, to support optimal surgical handling and implantation; can extend a smaller quantity of autograft than is normally required to achieve a solid spinal arthrodesis, consequently, a reduced amount of harvested autograft may be required, potentially diminishing the risk and severity of donor site complications
Also Known As:
Grafton DBM
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Block, Jon E:
2 articles
(01/2007 - 10/2006)
|
2. | Stubbs, Harrison A:
2 articles
(01/2007 - 10/2006)
|
3. | Buchman, Steven R:
1 article
(06/2021)
|
4. | Makar, Katelyn G:
1 article
(06/2021)
|
5. | Vercler, Christian J:
1 article
(06/2021)
|
6. | Armstrong, Douglas G:
1 article
(05/2008)
|
7. | Blakemore, Laurel C:
1 article
(05/2008)
|
8. | Poe-Kochert, Connie:
1 article
(05/2008)
|
9. | Son-Hing, Jochen P:
1 article
(05/2008)
|
10. | Thompson, George H:
1 article
(05/2008)
|
Related Diseases
Related Therapies and Procedures